CAMBRIDGE, Mass., Apr 26, 2012 (BUSINESS WIRE) --AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that financial
results for the company's first quarter ended March 31, 2012 will be
released before the market opens on Thursday, May 3, 2012. The AVEO
management team will host a conference call discussing the company's
financial results and recent developments on Thursday, May 3, 2012 at
10:00 a.m. (ET). The call can be accessed by dialing 1-866-277-1182
(domestic) or 1-617-597-5359 (international) five minutes prior to the
start of the call and providing the passcode 71124634. A replay of the
call will be available approximately two hours after the completion of
the call and can be accessed by dialing 1-888-286-8010 (domestic) or
1-617-801-6888 (international), providing the passcode 67072515. The
replay will be available for two weeks from the date of the call.
The listen-only webcast of the conference call can be accessed by
visiting the investors section of the AVEO website at http://investor.aveopharma.com.
A replay of the webcast will be archived on the company's website for
two weeks following the call.
AVEO Pharmaceuticals (Nasdaq: AVEO) is a cancer therapeutics company
committed to discovering, developing and commercializing targeted
therapies to impact patients' lives. AVEO's proprietary Human Response
Platform(TM) provides the company unique insights into cancer biology and
is being leveraged in the discovery and clinical development of its
cancer therapeutics. For more information, please visit the company's
website at www.aveopharma.com.
SOURCE: AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc.
Caton Lovett, 910-232-7166